Dr. Agarwals Health Care Receives GST Show Cause Notice
Dr. Agarwals Health Care Ltd announced it has been issued a Show Cause Notice (SCN) by the Goods and Services Tax (GST) authorities regarding alleged discrepancies in its tax filings for the financial year 2023-24. The authorities have indicated a potential demand of ₹20.50 crore, which includes interest and penalties.
Company Responds to Tax Inquiry
The notice, received on May 18, 2026, prompts the company to address potential issues related to output turnover, tax payments, input tax credit (ITC) claims, and e-invoicing compliance. Dr. Agarwals Health Care plans to submit a formal response within 30 days of receiving the notice. This is the first time the company has publicly disclosed such a notice.
Potential Financial Impact and Risks
Shareholders are advised to note the potential liabilities that could arise if the company's allegations are not successfully contested. The primary risk is the financial impact if the ₹20.50 crore demand, including interest and penalties, is ultimately levied. Failure to provide an adequate response within the stipulated 30 days could lead to an adverse order from the GST department.
What to Monitor Next
Investors will be tracking the company's submission of its reply to the GST authorities. Any further communication or orders from the GST department will be crucial. Confirmation from the company regarding any material financial impact is also important to monitor.
